Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1125816 Wheaton, IL
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$5,749,534
+$3,260,608 QoQ
Shares Held
339,807
+22.7% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 330 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. NTLA ranks #62 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 547,132 $341,158,687
2 INCY
Incyte Corp
 1,587,996 $180,015,226
3 CORT
Corcept Therapeutics Inc
 1,829,545 $159,078,937
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,179 $143,643,884
5 EXEL
Exelixis, Inc.
 2,543,353 $138,383,836
6 ALNY
Alnylam Pharmaceuticals, Inc.
 421,534 $126,894,380
7 KRYS
Krystal Biotech, Inc.
 324,900 $120,755,583
8 AXSM
Axsome Therapeutics, Inc.
 482,061 $117,994,070

All Filings in NTLA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,749,534 339,807
2025-12-31 $2,488,926 276,855
2025-09-30 $184,374 10,676
2025-06-30 $95,938 10,228
2024-03-31 $1,415,059 51,438
2023-09-30 $1,050,036 33,208
2021-12-31 $8,428,383 71,282
2021-09-30 $8,780,922 65,456
2021-06-30 $11,390,530 70,351
2021-03-31 $7,648,060 95,297
2020-12-31 $3,808,761 70,014